Pharmafile Logo
Pharmafocus logo
Advanced Search

drugs

Showing 15 posts of 771 posts found.

bms

BMS’ Opdivo gets a potential first-line boost in kidney cancer

September 8, 2017
Medical Communications, Research and Development Bristol-Myers Squibb, biotech, drugs, opdivo, pharma, pharmaceutical

Bristol-Myers Squibb has announced results from a Phase 3 trial showing that patients treated with Opdivo alongside Yervoy in patients …

News
1280px-niagara_river

Antidepressants polluting rivers building up in brains of fish

September 7, 2017
Medical Communications antidepressants, biotech, drugs, pharma, pharmaceutical

A study of ecosystem of the Niagara River has discovered that antidepressants are building up in the brains of fish. …

News
tom-graney_portrait

Vertex Pharma bring in new CFO, shares rise

September 7, 2017
Ironwood Pharmaceuticals, Vertex pharmaceuticals, biotech, drugs, pharma, pharmaceutical

Vertex Pharmaceuticals announced the appointment of J&J veteran, Tom Graney, as Senior Vice President and Chief Financial Officer. Graney will …

Appointment
spotleukaemia

Spotting Leukaemia

September 7, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, leukaemia, pharma, pharmaceutical

Leukaemia is a household name, but how much do we really understand about it? Not enough, says Bethany Torr, Campaigns …

Feature
bms_4

BMS hit by clinical trial hold from FDA

September 7, 2017
Medical Communications, Sales and Marketing Bristol-Myers Squibb, biotech, drugs, immunotherapy, opdivo, pharma, pharmaceutical

The FDA has placed a partial hold on clinical trials involving Bristol-Myers Squibb’s immunotherapy treatment, Opdivo, when used in combination …

News
merckwindowweb

MSD plays catch up with €464m deal for fledgling biotech

September 7, 2017
Sales and Marketing Bristol-Myers Squibb, MSD, biotech, drugs, keytruda, pharma, pharmaceutical

MSD has announced that it will acquire Rigontec, a three-year old German biotech, in a deal worth an initial €115 …

News

Takeda’s Ninlaro knocked back by NICE for second time

September 5, 2017
Research and Development, Sales and Marketing Ninlaro, Takeda, biotech, drugs, pharma, pharmaceutical

NICE has revealed that the outcome of its consultation process for Ninlaro (ixazomib), Takeda’s treatment for relapsed or refractory multiple …

News
pfizer-building-logo1web

Pfizer’s drug back on the market after proving safety

September 5, 2017
Manufacturing and Production, Sales and Marketing Mylotarg, Pfizer, biotech, drugs, pharma, pharmaceutical

Back in 2000, Pfizer had a drug that was granted accelerated approval for the treatment of acute myeloid leukaemia (AML) …

News
merck_kgaa_pyramid_use_with_credit

Merck KGaA to streamline business with $1bn healthcare sale

September 5, 2017
Manufacturing and Production, Sales and Marketing GSK, Merck KGaA, biotech, drugs, pharma, pharmaceutical

Merck KGaA has revealed that it is looking to sell its consumer healthcare business, in order to refocus the business …

News
gavel

Patently problematic? The impact of the Eli Lilly/Actavis intellectual property battle

September 4, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actavis, Eli Lilly, biotech, drugs, pemetrexed, pharma, pharmaceutical

The UK Supreme Court has sent shockwaves through the intellectual property world with its recent decision on Eli Lilly v …

Feature
nhs_trees_brett_wells_source_web

NHS needs emergency £350 million to survive winter

September 4, 2017
Medical Communications, Sales and Marketing NHS, biotech, drugs, pharma, pharmaceutical

NHS Providers has stated that £350 million needs to be injected into the NHS to avoid the ‘humanitarian crisis’ that …

News

Sanofi backs out of controversial Zika vaccine project

September 4, 2017
Research and Development, Sales and Marketing Sanofi, US, Vaccine, Zika, biotech, drugs, pharma, pharmaceutical

Sanofi’s development of a Zika vaccine, alongside the US’s Biomedical Advanced Research and Development Authority (BARDA), has hit the headlines …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 1, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Trump, drugs, health, life sciences, medicine, pharma, pharmaceutical, top ten

This week saw the news of a breakthrough in bispecific antibody production and Merck KGaA finally secured approval for its …

News

R&D tax credits: A novel approach to supply chain funding

September 1, 2017
Manufacturing and Production, Medical Communications, Research and Development biotech, drugs, pharma, pharmaceutical, tax credits

Jenny Tragner, director at R&D tax credit consultancy ForrestBrown and member of HMRC’s R&D Consultative Committee, says R&D tax credits …

News

NHS pumps £100m into GP recruitment as numbers plummet

September 1, 2017
Medical Communications GP, NHS, biotech, drugs, pharma, pharmaceutical

The NHS has been forced to offer £100 million to recruitment agencies in order to plug growing gaps in the …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025